Randomized phase III study of fludarabine phosphate versus cyclophosphamide, vincristine, and prednisone in patients with recurrent low-grade non-Hodgkin's lymphoma previously treated with an alkylating agent or alkylator-containing regimen. [electronic resource]
Producer: 20030115Description: 4649-54 p. digitalISSN:- 0732-183X
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Cyclophosphamide -- administration & dosage
- Drug Administration Schedule
- Female
- Humans
- Lymphoma, Non-Hodgkin -- drug therapy
- Male
- Middle Aged
- Prednisone -- administration & dosage
- Quality of Life
- Survival Rate
- Treatment Outcome
- Vidarabine -- administration & dosage
- Vincristine -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase III; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.